Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06920563 · ClinicalTrials.gov registry record · NA

Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education

A NA study of Gestational Hypertension and Pre-Eclampsia; Complicating Pregnancy, sponsored by Ochsner Health System.

Recruiting
Registry status
NA
Development phase
296
Enrollment target
1
Study location

NCT06920563: Recruiting NA study of Gestational Hypertension and Pre-Eclampsia; Complicating Pregnancy, sponsored by Ochsner Health System.

NCT06920563 is a NA study of Gestational Hypertension and Pre-Eclampsia; Complicating Pregnancy that is actively recruiting participants, run by Ochsner Health System. The registered enrollment target is 296 participants, below the 1,341-participant average among 18 other Gestational Hypertension trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06920563, a NA study of Gestational Hypertension and Pre-Eclampsia; Complicating Pregnancy, is actively recruiting participants, sponsored by Ochsner Health System.

RECRUITING
Registry status
NA
Development phase
296 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes? Participants will: View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum

Primary Outcome

Engagement will be defined by frequency of use: number of remote BP measurements ascertained during the 6 week postpartum period.

Interventions

  • OTHER Video
  • OTHER Text Reminder
  • OTHER Blood pressure threshold

Study Locations (1)

Louisiana

  • Ochsner Baptist - New Orleans

Trial Details

FieldValue
Enrollment Target 296 participants
Start Date 2025-03-17
Est. Completion 2026-10-16
Phase NA
Ochsner Health System

29 total trials

What NCT06920563 shows while recruiting

NCT06920563 is an interventional study that assigns participants to a tested intervention. The registered 296 participants enrollment target is mid-sized for trials with a published cap, below the 1,341-participant average among 18 other Gestational Hypertension trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with Gestational Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Video is the first listed.

NCT06920563 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT06920563 about?

NCT06920563 is a clinical study titled "Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education". The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with edu...

What is the current status of trial NCT06920563?

This trial is currently recruiting. It is a NA study. The enrollment target is 296 participants. The study started on 2025-03-17. Estimated completion is 2026-10-16.

What conditions does trial NCT06920563 study?

This clinical trial studies the following conditions: Gestational Hypertension, Pre-Eclampsia; Complicating Pregnancy.

What interventions are being tested in trial NCT06920563?

The interventions under investigation include: Video (OTHER), Text Reminder (OTHER), Blood pressure threshold (OTHER).

Who is sponsoring clinical trial NCT06920563?

This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06920563 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06920563's enrollment target sits among peer trials

296 4th of 18 higher than 15 of 18 other Gestational Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gestational Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05563792 · 296 participants · NA

    Options for Pain Management Using Nonpharmacological Strategies

  • NCT06828445 · 296 participants · Phase 1

    Increasing Affordable Fruits and Vegetables for Families With Food Insecurity

  • NCT06309160 · 297 participants · NA

    COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD

  • NCT06375811 · 297 participants · Phase 3

    Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06920563, the US trial registry maintained by the National Library of Medicine. NCT06920563 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.